Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. The intrarenal role of angiotensin II in the recovery of urinary concentration after frusemide was examined in anaesthetized dogs by the intrarenal infusion of angiotensin II antagonists. 2. Renin secretion and renal inner medullary blood flow (tissue clearance of intraparenchymatously injected 133Xenon) were simultaneously measured before and 3 h after frusemide injection. 3. Intrarenal angiotensin II blockade delayed the recovery of urinary osmolality after frusemide. 4. An inverse relationship was found between
renin
secretion and renal inner medullary blood flow.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Intrarenal control of urine concentration by angiotensin II. 28 57
1. Aorta homogenate contains
renin
-like activity which on incubation generates angiotensin I over a wide pH range. 2. Rat aortic
renin
measured at an incubation pH of 6.5 rose and fell in parallel to plasma
renin
with salt depletion and salt-loading respectively. Renin little relationship with plasma
renin
. 3. Aortic
renin
(pH 6.5) was elevated in Goldblatt-two kidney hypertension and slowly fell for 24h after bilateral nephrectomy whereas the fall in plasma
renin
was complete by the first hour. Aortic
renin
(pH 5.3) was also high, but did not fall after bilateral nephrectomy. 4. Aortic
renin
(pH 6.5) is probably derived from plasma
renin
whereas
renin
measured at pH 5.3 is probably a tissue
renin
. 5. The prolonged half-life of aortic
renin
(pH 6.5) explains the observation that the
renin
-angiotensin system appears to be active in maintaining blood pressure for several hours after bilateral nephrectomy whereas the decline in plasma
renin
is rapid and does not continue significantly beyond 1 h.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Role of persistent vascular renin after bilateral nephrectomy in Goldblatt-two kidney hypertension. 28 58
1. The role of vasopressin in blood pressure control and in the pathogenesis of one-kidney Goldblatt hypertension in the conscious dog was investigated. 2. Infusion of synthetic arginine vasopressin to elevate plasma levels approximately five-fold caused bradycardia in normal dogs and increase in mean arterial blood pressure in dogs with pharmacological autonomic blockade. 3. A similar degree of elevation of plasma vasopressin concentration was observed after mild non-hypotensive haemorrhage. 4. Renal artery constriction in unilaterally-nephrectomized dogs caused a rise in plasma
renin
activity and only a doubling of plasma vasopressin concentration, but a marked rise in mean arterial blood pressure. 5. Vasopressin may play a role in normal cardiovascular homeostatic responses, but its role in the pathogenesis of this form of hypertension is unlikely to be significant.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:The role of vasopressin in blood pressure control and in experimental hypertension. 28 63
1. Pronounced hypoaldosteronism was found in five young women with low-
renin
hypertension and characteristic features of the mineralocorticoid hypertensive syndrome. 2. There was no overproduction of the mineralocorticoids 11-deoxycorticosterone and 18-OH-11-deoxycorticosterone. 3. Dexamethasone restored blood pressure to normal, decreased body weight, increased plasma potassium, and increased plasma
renin
activity and aldosterone excretion in all patients. 4. The data suggest overproduction of an unknown adrenocorticotrophic hormone-dependent mineralocorticoid maintaining hypertension in these patients.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Evidence for an unidentified, adrenocorticotrophic hormone-dependent mineralocorticoid maintaining hypertension in young women with hypoaldosteronism. 28 66
1. Labetalol was administered to 18 hypertensive patients for an average duration of 2.44 weeks, with an average final daily dose of 1.65 g. 2. Labetalol decreased resting heart rate by 16% and maximal exercise heart rate by 21%; the phenylephrine-induced rise of systolic brachial artery pressure was reduced by 36%. 3. During labetalol brachial artery pressure was lowered by 29/15 mmHg in the recumbent position, by 41/23 mmHg at rest sitting, and by 53/23 mmHg at maximal exercise; total peripheral resistance was not significantly affected at rest recumbent, but was reduced at sitting and at exercise; cardiac output decreased in all conditions. 4. Labetalol reduced mean pulmonary artery and capillary wedge pressures only in the sitting position. Pulmonary vascular resistance remained unchanged. 5. The drug produced significant decreases of plasma
renin
activity and of plasma aldosterone concentration.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients. 28 68
1. Plasma
renin
activity, response to saralasin and exchangeable sodium have been measured in 43 patients with early renal disease. 2. Blood pressure was directly proportional to plasma
renin
activity. However, mean plasma
renin
activity was lower in patients with renal disease than in normal controls. 3. Blood pressure fell in response to saralasin infusion in proportion to the pre-infusion plasma
renin
activity. 4. Exchangeable sodium in hypertensive patients with renal disease did not exceed that in normotensive patients in contrast to earlier reports. Discrepancies may arise from the difficulty in interpreting measured exchangeable sodium in relation to body build.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Sodium and renin in the hypertension of early renal disease. 28 72
1. The pressor role of
renin
stimulated by chronic diuretic therapy has been assessed in 31 patients with essential hypertension by infusing the angiotensin II antagonist, saralasin, immediately before and at the end of 2 weeks' treatment with the diuretic, chlorthalidone. 2. Under diuretic therapy the change in blood pressure caused by saralasin was found to be correlated to plasma
renin
activity values, in such a way that small pressor responses were again observed in patients whose
renin
was mildly stimulated by the diuretic, whereas a marked depressor response occurred in patients whose
renin
was markedly increased. 3. On the other hand, the hypotensive effect of chlorthalidone was correlated to values of plasma
renin
activity under diuretic therapy in an opposite direction: indeed little or no decrease and sometimes an increase in blood pressure were observed in patients with marked
renin
activation by diuretic therapy. 4. It is concluded that stimulation of
renin
release by chronic diuretic therapy can be considered a factor limiting the hypotensive activity of diuretic drugs.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Relationship between the hypotensive and renin-stimulating actions of diuretic therapy in hypertensive patients. 28 74
1. The effects of oral administration of 4.5 mg of prazosin/day on blood pressure and on plasma
renin
activity were assessed in patients with essential hypertension and in healthy normotensive volunteer subjects. 2. Mean blood pressure in the hypertensive group fell significantly within 2 weeks of treatment, whereas heart rate was little affected. None of the parameters measured in the normotensive subjects during treatment with prazosin revealed significant changes. 3. Sub-classification of the hypertensive patients into low-, normal- and high-
renin
categories revealed significant decreases of
renin
in all six patients with high
renin
- and in four out of 12 patients with normal
renin
- but not in the two patients with low
renin
-essential hypertension. 4. The results indicate the prazosin exerts its hypotensive action and suppresses plasma
renin
activity particularly in patients with high
renin
-essential hypertension. These may be considered to have increased sympathetic drive. 5. Conceivably, the blood pressure-lowering effect of prazosin is affected by peripheral vasodilatation and also by a decreased venous return to the heart.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Effect of prazosin on blood pressure and plasma renin activity in man. 28 80
1. Blood pressure, plasma
renin
activity, plasma aldosterone, urinary noradrenaline during sleep (UNA-S) and several estimates of sodium intake were determined in 379 normotensive subjects (age 13--70) to investigate the relationship of these variables to blood pressure. 2. Blood pressure was correlated with age, weight, plasma
renin
activity UNA-S, and estimates of sodium intake. There variables were frequently intercorrelated. 3. Multiple-correlation analysis revealed that after removal of the effects of age, blood pressure was related to weight, plasma
renin
activity, UNA-S and estimates of sodium intake. 4. However, multiple-regression analysis failed to demonstrate an effect of plasma
renin
activity, UNA-S, or estimates of sodium intake on blood pressure when the effects of age, weight, race and sex were removed. 5. Careful matching of subjects by age, weight, race and sex in studies of blood pressure and biochemical factors in normal subjects is crucial to proper interpretation of such data.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Biochemical correlates of the increase in blood pressure with age. 28 91
1. Plasma noradrenaline concentration and plasma
renin
activity were measured in a control, British, urban population (n = 115) in which blacks were matched for age and sex with whites. 2. Similar measurements were made in subjects with essential hypertension (77 white and 23 black), and 48 healthy normotensive white civil servants. 3. In controls blood pressure was significantly higher in blacks; it correlated with age in both races and with pulse rate in blacks. There were no significant racial differences in plasma noradrenaline which was positively correlated with age in both blacks and whites. Mean plasma
renin
activity was 55% lower in blacks, and this difference was not related to urinary sodium excretion. 4. In hypertensive subjects plasma noradrenaline positively correlated with age in blacks. This relationship was not found in whites in whom 20% of young hypertensive subjects (less than 45 years) had significantly raised plasma noradrenaline. Plasma
renin
activity was again significantly lower in blacks. In white hypertensives plasma noradrenaline and
renin
activity were significantly correlated. 5. There may be racial differences in the pathogenesis of essential hypertension.
Clin Sci
Mol
Med Suppl 1978 Dec
PMID:Are racial differences in essential hypertension due to different pathogenetic mechanisms? 28 93
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>